KEAP1 and Parkinson disease: Conversely, several studies have shown that genetic ablation/suppression of KEAP1, which results in constitutive upregulation of the NRF2 signaling cascade, improves neuronal survival and decreases PD phenotypes both in vitro and in vivo (Satoh et al., 2009; Williamson et al., 2012).